HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular study of Nucleophosmin 1(NPM1) gene in acute myeloid leukemia in Kurdish population.

AbstractBACKGROUND:
In patients with Acute Myeloid Leukemia (AML) the most frequent acquired molecular abnormalities and important prognostic indicators is nucleophosmin-1 (NPM1) mutations. Our study aims was molecular study of Nucleophosmin -1 gene in Acute Myeloid Leukemia in Kurdish population.
PATIENTS &METHODS:
A total of 50 patients with AML, (36) of them attended Nanakaly Hospital and (14) attended Hiwa Hospital and 30 healthy subjects as control were selected randomly, all were matched of age and gender. Polymerase chain reaction (PCR) was used for detection of NPM1 gene mutation. Three samples of PCR product for NPM1 gene mutations were sequenced, and mutations were determined by comparison with the normal NPM1 sequence NCBI (GenBank accession number NM_002520).
RESULTS:
Out of 50 patients with AML, 5 (10%) of them were NPM1 gene mutation positive, and 45 (90%) were negative. The mutation were a base substitution (C to A), (G to C), (G to T), transversion mutation in addition of frame shift mutation and all mutated cases were heterozygous and retained a wild type allele.
CONCLUSION:
Identification of NPM1 mutations in AML are important for prognostication, treatment decision and optimization of patient care.
AuthorsGalawezh Obaid Othman, Nawsherwan Sadiq Mohammad, Chiman Hameed Saeed
JournalAfrican health sciences (Afr Health Sci) Vol. 21 Issue 2 Pg. 687-692 (Jun 2021) ISSN: 1729-0503 [Electronic] Uganda
PMID34795724 (Publication Type: Journal Article)
Copyright© 2021 Othman GO et al.
Chemical References
  • Nucleophosmin
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Iraq
  • Leukemia, Myeloid, Acute (genetics)
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Nucleophosmin (genetics)
  • Polymerase Chain Reaction
  • Polymorphism, Genetic
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: